Hudson Bay Capital Management »

Oramed Pharm shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $176k 52k 3.40

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Oramed Pharm

BML Capital Management
Aquamarine Financial
Mercer Global Advisors
SB Capital Management
Murchinson
Boothbay Fund Management
Marshall Wace
Rathbones Brothers
Dimensional Fund Advisors
Wells Fargo & Company
Comprehensive Portfolio Management
Renaissance Technologies
Bank of America Corporation
O'shaughnessy Asset Management
Citadel Advisors

View all funds holding Oramed Pharm